In the August 2018 edition of Hogan Lovells’ Standard Essential Patent (SEP) Update, we report on recent news and case decisions from China, Germany, the United Kingdom, and the United States. This bi-monthly newsletter...more
9/14/2018
/ 35 U.S.C. § 271(f)(2) ,
35 U.S.C. § 284 ,
America Invents Act ,
Broadest Reasonable Interpretation Standard ,
Claim Construction ,
Domestic Injury ,
Extraterritoriality Rules ,
Foreign Sales ,
German Federal Supreme Court ,
Germany ,
Lost Profits ,
On-Sale Bar ,
Patent Infringement ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patent-Eligible Subject Matter ,
Patents ,
Rulemaking Process ,
SCOTUS ,
Section 101 ,
Teva Pharmaceuticals ,
Unified Patent Court ,
USPTO ,
WesternGeco LLC v Ion Geophysical Corporation
The prominent state of patent litigation in the United States and Germany is due not only to the size of its markets, but also to a recent increase in hearings before the U.S. International Trade Commission and the Patent...more
7/23/2018
/ 35 U.S.C. § 271(f)(2) ,
35 U.S.C. § 284 ,
America Invents Act ,
Broadest Reasonable Interpretation Standard ,
Claim Construction ,
Domestic Injury ,
EU ,
European Patent Office ,
Extraterritoriality Rules ,
Foreign Sales ,
Germany ,
Intellectual Property Protection ,
Lost Profits ,
On-Sale Bar ,
Patent Infringement ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patent Validity ,
Patent-Eligible Subject Matter ,
Patents ,
Petition for Writ of Certiorari ,
SCOTUS ,
Section 101 ,
Teva Pharmaceuticals ,
Unified Patent Court ,
USPTO ,
WesternGeco LLC v Ion Geophysical Corporation